Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Jan Henrik Terheyden1, Matthias M Mauschitz2, Maximilian W M Wintergerst2,3

  • 1Universitäts-Augenklinik Bonn, Venusberg-Campus 1, 53127, Bonn, Deutschland. jan.terheyden@ukbonn.de.

Die Ophthalmologie
|November 11, 2024
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Determinants of vision-related quality of life in recessive Stargardt disease.

The British journal of ophthalmology·2026
Same author

HTRA1/lncRNA HTRA1-AS1 dominates in age-related macular degeneration reticular pseudodrusen genetic risk with no complement involvement.

Nature communications·2025
Same author

Use of patient-reported outcome measures in everyday clinical practice in ophthalmology: results of a European multicountry survey.

The British journal of ophthalmology·2025
Same author

A new generation of patient-reported outcome measures with large language models.

Journal of patient-reported outcomes·2025
Same author

Imaging of ophthalmic manifestations: optical coherence tomography angiography and transorbital ultrasound in giant cell arteritis.

Rheumatology international·2025
Same author

Validating candidate endpoints for intermediate age-related macular degeneration trials in a multi-centre setting-lessons from the MACUSTAR study.

Eye (London, England)·2025
Same journal

[Real-world experience with aflibercept 8 mg for treatment of neovascular age-related macular degeneration after 12 months].

Die Ophthalmologie·2026
Same journal

[Vertigo and oculomotor disorders: diagnosis, anatomical classification and etiology].

Die Ophthalmologie·2026
Same journal

Die Ophthalmologie·2026
Same journal

[Calculating IOL power - principles, development and current challenges].

Die Ophthalmologie·2026
Same journal

[More than just technology: autonomous AI in ophthalmological care].

Die Ophthalmologie·2026
Same journal

[Is less more in individual cases? Minimal treatment for squamous cell carcinoma of the conjunctiva with orbital invasion].

Die Ophthalmologie·2026
See all related articles